Form 4 Tracker
John L Lamattina

Director · 3 filings · Latest: Jun 10, 2026

LIGAND PHARMACEUTICALS INC
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
LGND
John L LamattinaDirectorJun 10, 2026
Sale
$250.884,591$1.2M26,969
LGND
John L LamattinaDirectorJun 5, 2026
Grant/Award
$0.0083631,560
LGND
John L LamattinaDirectorMar 6, 2026
Sale
$200.762,161$433.8K30,724
LGND
John L LamattinaDirectorMar 6, 2026
Option Exercise
$114.152,161$246.7K32,885